Glycoprotein nonmetastatic B as a pharmacological target in cancer: structural mechanisms, druggability, and therapeutic translation

Biochemical Pharmacology · Published 2026-07-26 · DOI 10.1016/j.bcp.2026.118289

Authors (4)

Haixia Wang, Ruiming Wen, Zhongwei Yang, Luodan Yang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Wang, H., Wen, R., Yang, Z., et al. (2026). Glycoprotein nonmetastatic B as a pharmacological target in cancer: structural mechanisms, druggability, and therapeutic translation. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.118289

Related articles

• AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapy · Cell · 2026 · Cites or is cited by this article
• GPNMB immunohistochemistry distinguishes diagnostically challenging cases of lymphangioleiomyomatosis from other mesenchymal neoplasms presenting with cystic lung metastases · Human Pathology · 2026 · Cites or is cited by this article
• CAR T targets: AI takes the wheel · Cell · 2026 · Cites or is cited by this article
• Targeting RIPK1 for the treatment of depression: From neuroinflammation to synaptic plasticity · Biochemical Pharmacology · 2026 · Same journal
• BiP-engaging xanthones from the mangosteen (Garcinia mangostana) induce androgen receptor degradation in prostate cancer cells · Biochemical Pharmacology · 2026 · Same journal
• Advanced therapy medicinal products for local treatment using new delivery methods · Biochemical Pharmacology · 2026 · Same journal
• Genetic polymorphisms of drug-metabolizing cytochromes P450 and flavin-containing monooxygenases in dogs and pigs inform the prediction of drug metabolism and toxicity in humans and other animal species · Biochemical Pharmacology · 2026 · Same journal
• CerS2/ceramide C24:1/ROCK2 signaling-mediated angiogenesis protects against ischemic brain injury in mice · Biochemical Pharmacology · 2026 · Same journal
• Core genes drive treatment resistance in triple-negative breast cancer: characteristics, mechanisms, intervention strategies · Biochemical Pharmacology · 2026 · Same journal
• HDAC1-mediated PKM2 delactylation modification regulates CIRP-induced angiogenesis in rheumatoid arthritis · Biochemical Pharmacology · 2026 · Same journal